Brief: 3Sbio Inc Says Cipterbin Accepted For Listing On 2020 National Reimbursement Drug List

3SBio

28/12/2020 15:10

Dec 28 (Reuters) - 3SBio Inc  1530.HK :
    * CIPTERBIN ACCEPTED FOR LISTING ON 2020 NATIONAL
REIMBURSEMENT
DRUG LIST
    * TPIAO WAS ALSO ACCEPTED FOR LISTING ON 2020 NRDL

Source text for Eikon:  ID:nHKSbV9gJM 
Further company coverage:  1530.HK 

 ((Reuters.Briefs@thomsonreuters.com;))